Acute dilated cardiomyopathy in a patient with deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase

Pediatric Cardiology

Volumn 30, Issue 4, 2009, Pages 523-526

  Dyke II, Peter C ^a   Konczal, Laura ^a   Bartholomew, Dennis ^a   McBride, Kim L ^a   Hoffman, Timothy M ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Fatty acid metabolism; Heart failure; Inborn errors of metabolism; Long chain 3 hydroxyacyl CoA dehydrogenase deficiency

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE;

ANAMNESIS; ARTICLE; CARNITINE DEFICIENCY; CASE REPORT; CHILD; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ENZYME DEFICIENCY; FEMALE; HEART FUNCTION; HUMAN; LABORATORY TEST; PRESCHOOL CHILD;

ACUTE DISEASE; ACYL-COA DEHYDROGENASE, LONG-CHAIN; CARDIOMYOPATHY, DILATED; CHILD, PRESCHOOL; FEMALE; HUMANS;

EID: 67349099491     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-008-9351-8     Document Type: Article

References (23)

1. E Bertini C Dionisi-Vici B Garavaglia 1992 Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency Eur J Pediatr 151 121 126
2. D Bonnet D Martin L Pascale De 1999 Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children Circulation 100 2248 2253
3. P Colonna S Iliceto 2000 Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico Am Heart J 139 S124 S130
4. PB Corr KA Yamada 1995 Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis Herz 20 156 168
5. ME den Boer RJ Wanders AA Morris 2002 Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients Pediatrics 109 99 104 (Pubitemid 34049432)
6. MB Gillingham WE Connor D Matern 2003 Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Mol Genet Metab 79 114 123 (Pubitemid 36693930)
7. AM Glasgow AG Engel DM Bier 1983 Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency, and long-chain acylcarnitine excess responsive to medium chain triglyceride diet Pediatr Res 17 319 326 (Pubitemid 13135211)
8. L Hagenfeldt U von Dobeln E Holme 1990 3-Hydroxydicarboxylic aciduria-a fatty acid oxidation defect with severe prognosis J Pediatr 116 387 392 (Pubitemid 20109791)
9. E Helton R Darragh P Francis 2000 Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy Pediatrics 105 1260 1270 (Pubitemid 30346896)
10. S Jackson K Bartlett J Land 1991 Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Pediatr Res 29 406 411
11. E Martins A Costa E Silva 1996 Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency J Inherit Metab Dis 19 373 374 (Pubitemid 26185533)
12. SE Olpin S Clark BS Andresen 2005 Biochemical, clinical, and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency J Inherit Metab Dis 28 533 544 (Pubitemid 40753681)
13. R Pons M Roig E Riudor 1996 The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency Pediatr Neurol 14 236 243 (Pubitemid 26156290)
14. S Primassin F Ter Veld E Mayatepek U Spiekerkoetter 2008 Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine Pediatr Res 63 632 637
15. F Rocchiccioli RJ Wanders P Aubourg 1990 Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood Pediatr Res 28 657 662
16. Roe C, Ding J (2001) Chapter 101 mitochondrial fatty acid oxidation disorders. In: Scriver C, Beaudet A, Sly W et al (eds) The Metabolic and Molecular Bases of Inherited Diseases (MMBID). McGraw Hill, New York, pp 2297-2326
17. CR Roe DS Roe M Wallace B Garritson 2007 Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders Mol Genet Metab 92 346 350 (Pubitemid 350117714)
18. JM Saudubray D Martin P de Lonlay 1999 Recognition and management of fatty acid oxidation defects: a series of 107 patients J Inherit Metab Dis 22 488 502 (Pubitemid 29281037)
19. U Spiekerkoetter B Sun Z Khuchua 2003 Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations Hum Mutat 21 598 607 (Pubitemid 36667350)
20. T Tyni A Palotie L Viinikka 1997 Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients J Pediatr 130 67 76 (Pubitemid 27492721)
21. RJ Wanders L Ijlst M Duran 1991 Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients J Inherit Metab Dis 14 325 328
22. SC Winter 2003 Treatment of carnitine deficiency J Inherit Metab Dis 26 171 180 (Pubitemid 36889740)
23. SC Winter NR Buist 2000 Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine Am Heart J 139 S63 S69 (Pubitemid 30091770)